NCT03027960 Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects Status COMPLETED Phase PHASE1
NCT03026556 The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis Status COMPLETED Phase N/A
NCT03021265 To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension Status COMPLETED Phase N/A
NCT03018756 Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea Status COMPLETED Phase PHASE3
NCT03017885 Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy Status COMPLETED Phase N/A
NCT03004404 To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT03003494 Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy Status COMPLETED Phase N/A
NCT03000075 BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02999191 Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02999178 Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Status COMPLETED Phase PHASE3
NCT02998970 Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes Status UNKNOWN Phase PHASE4
NCT02982850 Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease Status COMPLETED Phase PHASE4
NCT02979977 Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck Status COMPLETED Phase PHASE2
NCT02978690 Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis Status COMPLETED Phase PHASE1
NCT02976519 BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects Status COMPLETED Phase PHASE1
NCT02969317 Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients Status COMPLETED Phase PHASE1